Pharmacokinetic/pharmacodynamic target attainment of intravenous β-lactam regimens against Gram-negative bacteria isolated in a Brazilian teaching hospital

ABSTRACTINTRODUCTION: Monte Carlo simulations have been used for selecting optimal antibiotic regimens for treatment of bacterial infections. The aim of this study was to assess the pharmacokinetic and pharmacodynamic target attainment of intravenous β-lactam regimens commonly used to treat bloodstr...

Full description

Bibliographic Details
Main Authors: Guilherme Henrique Furtado, Leandro Cardinal, Rodrigo Spineli Macedo, Juliana Oliveira Silva, Eduardo Alexandrino Medeiros, Joseph Levente Kuti, David Paul Nicolau
Format: Article
Language:English
Published: Sociedade Brasileira de Medicina Tropical (SBMT) 2015-10-01
Series:Revista da Sociedade Brasileira de Medicina Tropical
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822015000500539&lng=en&tlng=en
_version_ 1811244657165729792
author Guilherme Henrique Furtado
Leandro Cardinal
Rodrigo Spineli Macedo
Juliana Oliveira Silva
Eduardo Alexandrino Medeiros
Joseph Levente Kuti
David Paul Nicolau
author_facet Guilherme Henrique Furtado
Leandro Cardinal
Rodrigo Spineli Macedo
Juliana Oliveira Silva
Eduardo Alexandrino Medeiros
Joseph Levente Kuti
David Paul Nicolau
author_sort Guilherme Henrique Furtado
collection DOAJ
description ABSTRACTINTRODUCTION: Monte Carlo simulations have been used for selecting optimal antibiotic regimens for treatment of bacterial infections. The aim of this study was to assess the pharmacokinetic and pharmacodynamic target attainment of intravenous β-lactam regimens commonly used to treat bloodstream infections (BSIs) caused by Gram-negative rod-shaped organisms in a Brazilian teaching hospital.METHODS: In total, 5,000 patients were included in the Monte Carlo simulations of distinct antimicrobial regimens to estimate the likelihood of achieving free drug concentrations above the minimum inhibitory concentration (MIC; fT > MIC) for the requisite periods to clear distinct target organisms. Microbiological data were obtained from blood culture isolates harvested in our hospital from 2008 to 2010.RESULTS: In total, 614 bacterial isolates, including Escherichia coli, Enterobacterspp., Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa, were analyzed Piperacillin/tazobactam failed to achieve a cumulative fraction of response (CFR) > 90% for any of the isolates. While standard dosing (short infusion) of β-lactams achieved target attainment for BSIs caused by E. coliand Enterobacterspp., pharmacodynamic target attainment against K. pneumoniaeisolates was only achieved with ceftazidime and meropenem (prolonged infusion). Lastly, only prolonged infusion of high-dose meropenem approached an ideal CFR against P. aeruginosa; however, no antimicrobial regimen achieved an ideal CFR against A. baumannii.CONCLUSIONS:These data reinforce the use of prolonged infusions of high-dose β-lactam antimicrobials as a reasonable strategy for the treatment of BSIs caused by multidrug resistant Gram-negative bacteria in Brazil.
first_indexed 2024-04-12T14:29:00Z
format Article
id doaj.art-b62421cbaa9640fba3da7019e20232c6
institution Directory Open Access Journal
issn 1678-9849
language English
last_indexed 2024-04-12T14:29:00Z
publishDate 2015-10-01
publisher Sociedade Brasileira de Medicina Tropical (SBMT)
record_format Article
series Revista da Sociedade Brasileira de Medicina Tropical
spelling doaj.art-b62421cbaa9640fba3da7019e20232c62022-12-22T03:29:21ZengSociedade Brasileira de Medicina Tropical (SBMT)Revista da Sociedade Brasileira de Medicina Tropical1678-98492015-10-0148553954510.1590/0037-8682-0122-2015S0037-86822015000500539Pharmacokinetic/pharmacodynamic target attainment of intravenous β-lactam regimens against Gram-negative bacteria isolated in a Brazilian teaching hospitalGuilherme Henrique FurtadoLeandro CardinalRodrigo Spineli MacedoJuliana Oliveira SilvaEduardo Alexandrino MedeirosJoseph Levente KutiDavid Paul NicolauABSTRACTINTRODUCTION: Monte Carlo simulations have been used for selecting optimal antibiotic regimens for treatment of bacterial infections. The aim of this study was to assess the pharmacokinetic and pharmacodynamic target attainment of intravenous β-lactam regimens commonly used to treat bloodstream infections (BSIs) caused by Gram-negative rod-shaped organisms in a Brazilian teaching hospital.METHODS: In total, 5,000 patients were included in the Monte Carlo simulations of distinct antimicrobial regimens to estimate the likelihood of achieving free drug concentrations above the minimum inhibitory concentration (MIC; fT > MIC) for the requisite periods to clear distinct target organisms. Microbiological data were obtained from blood culture isolates harvested in our hospital from 2008 to 2010.RESULTS: In total, 614 bacterial isolates, including Escherichia coli, Enterobacterspp., Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa, were analyzed Piperacillin/tazobactam failed to achieve a cumulative fraction of response (CFR) > 90% for any of the isolates. While standard dosing (short infusion) of β-lactams achieved target attainment for BSIs caused by E. coliand Enterobacterspp., pharmacodynamic target attainment against K. pneumoniaeisolates was only achieved with ceftazidime and meropenem (prolonged infusion). Lastly, only prolonged infusion of high-dose meropenem approached an ideal CFR against P. aeruginosa; however, no antimicrobial regimen achieved an ideal CFR against A. baumannii.CONCLUSIONS:These data reinforce the use of prolonged infusions of high-dose β-lactam antimicrobials as a reasonable strategy for the treatment of BSIs caused by multidrug resistant Gram-negative bacteria in Brazil.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822015000500539&lng=en&tlng=enMonte Carlo simulationPharmacodynamicsGram-negative bacteriaBloodstream infections
spellingShingle Guilherme Henrique Furtado
Leandro Cardinal
Rodrigo Spineli Macedo
Juliana Oliveira Silva
Eduardo Alexandrino Medeiros
Joseph Levente Kuti
David Paul Nicolau
Pharmacokinetic/pharmacodynamic target attainment of intravenous β-lactam regimens against Gram-negative bacteria isolated in a Brazilian teaching hospital
Revista da Sociedade Brasileira de Medicina Tropical
Monte Carlo simulation
Pharmacodynamics
Gram-negative bacteria
Bloodstream infections
title Pharmacokinetic/pharmacodynamic target attainment of intravenous β-lactam regimens against Gram-negative bacteria isolated in a Brazilian teaching hospital
title_full Pharmacokinetic/pharmacodynamic target attainment of intravenous β-lactam regimens against Gram-negative bacteria isolated in a Brazilian teaching hospital
title_fullStr Pharmacokinetic/pharmacodynamic target attainment of intravenous β-lactam regimens against Gram-negative bacteria isolated in a Brazilian teaching hospital
title_full_unstemmed Pharmacokinetic/pharmacodynamic target attainment of intravenous β-lactam regimens against Gram-negative bacteria isolated in a Brazilian teaching hospital
title_short Pharmacokinetic/pharmacodynamic target attainment of intravenous β-lactam regimens against Gram-negative bacteria isolated in a Brazilian teaching hospital
title_sort pharmacokinetic pharmacodynamic target attainment of intravenous β lactam regimens against gram negative bacteria isolated in a brazilian teaching hospital
topic Monte Carlo simulation
Pharmacodynamics
Gram-negative bacteria
Bloodstream infections
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822015000500539&lng=en&tlng=en
work_keys_str_mv AT guilhermehenriquefurtado pharmacokineticpharmacodynamictargetattainmentofintravenousblactamregimensagainstgramnegativebacteriaisolatedinabrazilianteachinghospital
AT leandrocardinal pharmacokineticpharmacodynamictargetattainmentofintravenousblactamregimensagainstgramnegativebacteriaisolatedinabrazilianteachinghospital
AT rodrigospinelimacedo pharmacokineticpharmacodynamictargetattainmentofintravenousblactamregimensagainstgramnegativebacteriaisolatedinabrazilianteachinghospital
AT julianaoliveirasilva pharmacokineticpharmacodynamictargetattainmentofintravenousblactamregimensagainstgramnegativebacteriaisolatedinabrazilianteachinghospital
AT eduardoalexandrinomedeiros pharmacokineticpharmacodynamictargetattainmentofintravenousblactamregimensagainstgramnegativebacteriaisolatedinabrazilianteachinghospital
AT josephleventekuti pharmacokineticpharmacodynamictargetattainmentofintravenousblactamregimensagainstgramnegativebacteriaisolatedinabrazilianteachinghospital
AT davidpaulnicolau pharmacokineticpharmacodynamictargetattainmentofintravenousblactamregimensagainstgramnegativebacteriaisolatedinabrazilianteachinghospital